Recombinant HIV1 Protease protein

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HIV-1 protease also called aspartyl protease is an enzyme vital for the life cycle of the HIV virus. It has a molecular mass of around 22 kilodaltons. This protease cleaves the viral polyprotein precursors generating mature protein components essential for a functional viral particle. HIV-1 protease is expressed in the cytoplasmic region of HIV-infected cells. Its unique structure with a symmetrical dimer makes it an attractive target for antiviral drugs.

Biological function summary

HIV-1 protease functions to cleave the Gag and Gag-Pol polyprotein precursors into functional proteins. This proteolytic activity is essential in viral maturation and assembly transforming the virus into an infectious particle. HIV-1 protease does not form a complex with other proteins but operates independently to process numerous substrates within the viral lifecycle.

Pathways

HIV-1 protease participates in the HIV replication pathway. It is important for the maturation process directly impacting the infectivity of the virus. The enzyme operates alongside other viral enzymes such as reverse transcriptase and integrase together facilitating the spread of the virus within the host. The integration of the protease activity in these pathways is necessary for the progression of the virus from a latent to an active state.

HIV-1 protease plays a central role in the progression of Human Immunodeficiency Virus (HIV) and subsequent development of Acquired Immunodeficiency Syndrome (AIDS). Inhibitors targeting HIV-1 protease such as saquinavir and ritonavir act to halt the maturation of the virus and reduce viral load in patients. Connections exist between HIV-1 protease and CD4 receptor proteins which are targets in the pathogenesis of HIV. Understanding and targeting this protease remain important strategies in HIV/AIDS treatment and management.